| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5993830 | RESILIA PHARMS | Cosmetic skin preparation |
Jan, 2018
(6 years ago) | |
| US10071054 | RESILIA PHARMS | Econazole composition and methods of treatment therewith |
Aug, 2031
(7 years from now) | |
Ecoza is owned by Resilia Pharms.
Ecoza contains Econazole Nitrate.
Ecoza has a total of 2 drug patents out of which 1 drug patent has expired.
Expired drug patents of Ecoza are:
- US5993830
Ecoza was authorised for market use on 24 October, 2013.
Ecoza is available in aerosol, foam;topical dosage forms.
Ecoza can be used as method of alleviating a skin condition.
The generics of Ecoza are possible to be released after 08 August, 2031.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Dosage Form(NDF) | Oct 24, 2016 |
Drugs and Companies using ECONAZOLE NITRATE ingredient
Market Authorisation Date: 24 October, 2013
Treatment: Method of alleviating a skin condition
Dosage: AEROSOL, FOAM;TOPICAL
More Information on Dosage
ECOZA family patents
